Completed PHASE3 INTERVENTIONAL 2-arm NCT00137787

Comparing Ciprofloxacin (CPFX) With Cefepime (CFPM) in Febrile Neutropenic Patients With Hematologic Diseases

Randomized Controlled Trial Comparing Ciprofloxacin With Cefepime in Febrile Neutropenic Patients With Hematologic Diseases

Sponsor: Bayer

Conditions Febrile Neutropenia

Interventions cefepime ciprofloxacin

Updated 6 times since 2017 Last updated: Jun 25, 2018 Started: Apr 30, 2005 Primary completion: Dec 31, 2009 Completion: May 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Febrile Neutropenia and is currently completed. Bayer leads this study, which shows 6 recorded versions since 2005 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jul 2018 — Jan 2021 [monthly]

Completed PHASE3

Status: Unknown Status → Completed
Jun 2018 — Jul 2018 [monthly]

Unknown Status PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Apr 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bayer
Center for Supporting Hematology-Oncology Trials

Data source: Center for Supporting Hematology-Oncology Trials

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nagoya, Japan